Largest Biotechnology companies in United States by Market Capitalization

This ranking features the largest 511 Biotechnology companies in United States ranked by Market Capitalization, totaling a Market Capitalization of USD 2.74 T, for June 19, 2025.

#	Name	Share Price Year-To-Date (YTD) return Price to Earnings Ratio (P/E) Revenue EBIT EBITDA Net Income Free Cash Flow Dividend Yield Free Cash Flow Yield Total Assets Total Liabilities Cash and Short-Term Investments	Stock Price	Change	Price (30 days)	52W low/high	Sector

Items per page

1 2 3 4 … 11

Frequently Asked Questions

Which Biotechnology company in United States has the highest Market Capitalization ?

The Biotechnology company in United States with the highest Market Capitalization is AbbVie Inc. (NYSE: ABBV) at USD 327.65 B.
Which Biotechnology company in United States has the lowest Market Capitalization ?

The Biotechnology company in United States with the lowest Market Capitalization is EyeGate Pharmaceuticals, Inc. (NasdaqGM: EYEG) at None.

What are the top 10 Biotechnology companies in United States by Market Capitalization ?

The top 10 Biotechnology companies in United States by Market Capitalization are AbbVie Inc., Abbott Laboratories, Merck & Co., Inc., Amgen Inc., Boston Scientific Corporation, Thermo Fisher Scientific Inc., Danaher Corporation, Pfizer Inc., Gilead Sciences, Inc. and Vertex Pharmaceuticals Incorporated.
What are the bottom 10 Biotechnology companies in United States by Market Capitalization ?

The bottom 10 Biotechnology companies in United States by Market Capitalization are EyeGate Pharmaceuticals, Inc., Lixte Biotechnology Holdings, Inc., Alzamend Neuro, Inc., Bluejay Diagnostics, Inc., Applied DNA Sciences, Inc., iSpecimen Inc., NanoVibronix, Inc., Longevity Health Holdings Inc., NAYA Biosciences, Inc. Common Stock and Qualigen Therapeutics, Inc..